Cargando...
Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration–Approved Duration
OBJECTIVE: To evaluate the effectiveness of the contraceptive implant and the 52mg hormonal intrauterine device (IUD) in women using the method beyond the current U.S. Food and Drug Administration–approved duration of 3 and 5 years respectively. METHODS: Women willing to continue using their implant...
Guardado en:
| Publicado en: | Obstet Gynecol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4347947/ https://ncbi.nlm.nih.gov/pubmed/25730221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000000690 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|